Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | CRSP | IMVT | ||
| Company | Apellis Pharmaceuticals Inc | Crispr Therapeutics Ag | Immunovant Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.85 | 55.55 | 25.15 | ||
| High | 40.88 | 57.77 | 26.96 | ||
| Low | 40.78 | 55.35 | 25.04 | ||
| Latest | 40.85 | 56.86 | 26.55 | ||
| Change | +0.01 | +2.03 | +1.43 | ||
| % Change | +0.02% | +3.70% | +5.69% | ||
| Volume | 4,524,900 | 2,103,900 | 2,314,400 | ||
| 20-Day Average Volume | 9,908,250 | 1,582,285 | 1,468,850 | ||
| Previous Close | 40.84 | 54.83 | 25.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.11 | 49.01 | 24.58 | ||
| 20-Day Raw Stochastic | 99.90% | 93.33% | 90.17% | ||
| 20-Day Relative Strength | 83.03 | 59.81 | 55.43 | ||
| Weighted Alpha | +22.07 | +38.93 | +61.72 | ||
| Today's Opinion | 100% Buy | 8% Sell | 64% Buy | ||
| Previous Opinion | 100% Buy | 48% Sell | 24% Buy | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.37% since 04/07/26 | +14.41% since 04/07/26 | +7.88% since 04/07/26 | ||
| Low | 40.64 on 04/09/26 | 49.50 on 04/10/26 | 24.36 on 04/13/26 | ||
| High | 40.88 on 04/14/26 | 57.77 on 04/14/26 | 26.96 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +115.68% since 03/13/26 | +16.64% since 03/13/26 | +8.77% since 03/13/26 | ||
| Low | 16.83 on 03/30/26 | 44.12 on 03/30/26 | 22.79 on 03/20/26 | ||
| High | 40.88 on 04/14/26 | 57.77 on 04/14/26 | 26.96 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +100.93% since 01/14/26 | -0.05% since 01/14/26 | -2.93% since 01/14/26 | ||
| Low | 16.83 on 03/30/26 | 44.12 on 03/30/26 | 22.79 on 03/20/26 | ||
| High | 40.88 on 04/14/26 | 61.76 on 02/26/26 | 29.25 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +76.46% since 10/14/25 | -18.05% since 10/14/25 | +51.80% since 10/14/25 | ||
| Low | 16.83 on 03/30/26 | 44.12 on 03/30/26 | 17.02 on 10/17/25 | ||
| High | 40.88 on 04/14/26 | 75.06 on 10/21/25 | 29.25 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,220,577 | 5,262,858 | 5,112,724 | ||
| Shares Outstanding, K | 127,830 | 95,985 | 203,532 | ||
| Annual Sales | 1,003,780,000 | 3,510,000 | 0 | ||
| Annual Net Income | 22,390,000 | -581,600,000 | -413,840,000 | ||
| Last Quarter Sales | 199,910,000 | 860,000 | 0 | ||
| Last Quarter Net Income | -58,950,000 | -130,610,000 | -110,640,000 | ||
| 60-Month Beta | -0.19 | 1.80 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 02/24/26 | -1.37 on 02/12/26 | -0.61 on 02/06/26 | ||
| Latest Earnings Date | 05/06/26 | 05/05/26 | 06/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 313.77 | 0.00 | 0.00 | ||